JP2011507859A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507859A5
JP2011507859A5 JP2010539516A JP2010539516A JP2011507859A5 JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5 JP 2010539516 A JP2010539516 A JP 2010539516A JP 2010539516 A JP2010539516 A JP 2010539516A JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5
Authority
JP
Japan
Prior art keywords
connexin
composition
polynucleotide
oligonucleotide
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507859A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014024 external-priority patent/WO2009085273A2/en
Publication of JP2011507859A publication Critical patent/JP2011507859A/ja
Publication of JP2011507859A5 publication Critical patent/JP2011507859A5/ja
Pending legal-status Critical Current

Links

JP2010539516A 2007-12-21 2008-12-22 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 Pending JP2011507859A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US874807P 2007-12-21 2007-12-21
PCT/US2008/014024 WO2009085273A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin polynucleotides for the treatment of surgical adhesions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014173528A Division JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Publications (2)

Publication Number Publication Date
JP2011507859A JP2011507859A (ja) 2011-03-10
JP2011507859A5 true JP2011507859A5 (OSRAM) 2013-04-25

Family

ID=40824957

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539516A Pending JP2011507859A (ja) 2007-12-21 2008-12-22 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用
JP2014173528A Pending JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014173528A Pending JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Country Status (7)

Country Link
US (1) US20110144182A1 (OSRAM)
EP (1) EP2252689A2 (OSRAM)
JP (2) JP2011507859A (OSRAM)
AU (1) AU2008343754A1 (OSRAM)
CA (1) CA2710227A1 (OSRAM)
WO (1) WO2009085273A2 (OSRAM)
ZA (1) ZA201005220B (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006257283A1 (en) 2005-02-03 2006-12-21 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
JP2011507857A (ja) 2007-12-21 2011-03-10 コーダ セラピューティクス, インコーポレイテッド 線維症性の状態の処置のためのコネキシン43の阻害剤の使用
CN102985096B (zh) * 2010-04-13 2014-12-10 凯希特许有限公司 具有活性成分的组合物以及伤口敷料、设备和方法
JP6185937B2 (ja) 2012-03-01 2017-08-23 ファーストストリング・リサーチ・インコーポレイテッドFirststring Research,Inc. アルファコネキシンc末端(act)ペプチド含有局所用ゲル剤
JP2015513905A (ja) 2012-03-27 2015-05-18 コーダ セラピューティクス, インコーポレイテッド カドヘリン調節に基づく組成物および処置
US20130259854A1 (en) * 2012-04-02 2013-10-03 Saint Louis University, A Non-Profit Organization Methods and compositions for reducing the incidence of post-surgical adhesions
US10465188B2 (en) 2014-08-22 2019-11-05 Auckland Uniservices Limited Channel modulators
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
CN116710474A (zh) 2020-10-22 2023-09-05 撒凯尔生物公司 肽制剂及其眼科用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) * 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4861757A (en) * 1986-11-14 1989-08-29 Institute Of Molecular Biology Wound healing and bone regeneration using PDGF and IGF-I
JPH0539594Y2 (OSRAM) * 1988-08-05 1993-10-07
US5166195A (en) * 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
US20030148968A1 (en) * 1995-02-28 2003-08-07 Hammond H. Kirk Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
US6752987B1 (en) * 1995-02-28 2004-06-22 The Regents Of The University Of California Adenovirus encoding human adenylylcyclase (AC) VI
US6458590B1 (en) * 1997-08-07 2002-10-01 The United States Of America, As Represented By The Department Of Health And Human Services Methods and compositions for treatment of restenosis
WO1999029858A1 (en) * 1997-12-09 1999-06-17 Children's Medical Center Corporation Soluble inhibitors of vascular endothelial growth factor and use thereof
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
ATE533515T1 (de) * 1999-01-27 2011-12-15 Coda Therapeutics Inc Formulierungen enthaltend antisense nukleotide spezifisch für connexine
US5998148A (en) * 1999-04-08 1999-12-07 Isis Pharmaceuticals Inc. Antisense modulation of microtubule-associated protein 4 expression
CA2425662A1 (en) * 2000-10-18 2002-04-25 Children's Medical Center Corporation Osteopontin-coated surfaces and methods of use
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
WO2003032964A2 (en) * 2001-10-17 2003-04-24 University Of Wales College Of Medecine Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
JP2005516054A (ja) * 2002-01-29 2005-06-02 ワイス コネキシンヘミチャンネルを調節する組成物及びその方法
US20030215424A1 (en) * 2002-05-15 2003-11-20 Seul Kyung Hwan Method of modulating angiogenesis
AU2003265866A1 (en) * 2002-09-03 2004-03-29 Vit Lauermann Targeted release
WO2006006948A2 (en) * 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
US8034789B2 (en) * 2003-12-03 2011-10-11 Coda Therapeutics, Inc. Antisense compounds targeted to connexins and methods of use thereof
WO2006032143A1 (en) * 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
AU2006257283A1 (en) * 2005-02-03 2006-12-21 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
EP1973560A2 (en) * 2005-12-16 2008-10-01 Arla Foods amba Bovine osteopontin formulations for the improvement of the wound healing process
JP2010520181A (ja) * 2007-03-02 2010-06-10 ナショナル・ユニバーシティ・オブ・アイルランド・ゴルウェイ 心血管疾患の予測および治療のためのオステオポンチン
WO2009075882A2 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011507859A5 (OSRAM)
JP5607176B2 (ja) 新規ペプチドおよびその用途
US8668703B2 (en) Medical devices incorporating collagen inhibitors
US20090180965A1 (en) Methods for repair and regeneration of bone marrow
JP4307561B2 (ja) 創傷の治癒
JP2011507858A5 (OSRAM)
JP2014208699A (ja) 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
US9782522B2 (en) Compositions and methods for treating and preventing neointimal stenosis
JP2011507858A (ja) 整形外科状態の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた、抗コネキシンペプチドの使用
JP2011507599A5 (OSRAM)
JP2011507855A5 (OSRAM)
Hildebrand et al. Joint capsule matrix turnover in a rabbit model of chronic joint contractures: correlation with human contractures
DE602005025347D1 (de) Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
WO2013059879A1 (en) Compositions and methods for the treatment of fibrosis and fibrotic diseases
JP7129399B2 (ja) 哺乳動物における滑膜炎の予防および/または治療に使用するためのポリアクリルアミドヒドロゲル
TW201023879A (en) Method of inhibiting and/or rescuing cell terminal differentiation, and composition for treating and/or inhibiting arthritis
JP7514563B2 (ja) オルガノイドおよび抗炎症剤を含む炎症性腸疾患の予防または治療用薬学組成物
RU2425669C1 (ru) Средство для профилактики и лечения острого и хронического панкреатита
KR20240105439A (ko) 건-골 계면의 복구를 위한 방법 및 조성물
US20180214388A1 (en) Composition and method for reducing scarring
Meisel et al. Sunitinib inhibits postoperative adhesions in a rabbit model
US10596192B2 (en) Treating rotator cuff conditions
CN115120729B (zh) 跨膜蛋白41b作为药物靶标在制备治疗病理性心肌肥厚药物中的应用
DE502007003367D1 (de) Pharmazeutische zusammensetzung zur behandlung von inkontinenz